AC Immune SA (ACIU)
2.42
-0.07
(-2.81%)
USD |
NASDAQ |
May 02, 12:19
AC Immune Free Cash Flow (Quarterly): -17.38M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -17.38M |
September 30, 2023 | -15.99M |
June 30, 2023 | -16.44M |
March 31, 2023 | -18.36M |
December 31, 2022 | -19.05M |
September 30, 2022 | -14.11M |
June 30, 2022 | -19.64M |
March 31, 2022 | -25.64M |
December 31, 2021 | -20.54M |
September 30, 2021 | -16.03M |
June 30, 2021 | -18.15M |
March 31, 2021 | -20.04M |
December 31, 2020 | -20.73M |
September 30, 2020 | -18.49M |
June 30, 2020 | -15.86M |
March 31, 2020 | -10.23M |
December 31, 2019 | -13.97M |
September 30, 2019 | 17.69M |
Date | Value |
---|---|
June 30, 2019 | -15.75M |
March 31, 2019 | 65.71M |
December 31, 2018 | -12.46M |
September 30, 2018 | -12.20M |
June 30, 2018 | -7.092M |
March 31, 2018 | -15.21M |
December 31, 2017 | 7.166M |
September 30, 2017 | -8.651M |
June 30, 2017 | -10.34M |
March 31, 2017 | -12.43M |
December 31, 2016 | -7.319M |
September 30, 2016 | 8.408M |
June 30, 2016 | 0.2139M |
March 31, 2016 | -7.947M |
December 31, 2015 | -5.663M |
September 30, 2015 | 34.30M |
June 30, 2015 | -4.415M |
March 31, 2015 | 21.34M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-25.64M
Minimum
Mar 2022
17.69M
Maximum
Sep 2019
-15.72M
Average
-17.38M
Median
Dec 2023
Free Cash Flow (Quarterly) Benchmarks
CRISPR Therapeutics AG | -96.81M |
Addex Therapeutics Ltd | -0.5575M |
NLS Pharmaceutics Ltd | -- |
Molecular Partners AG | -17.34M |
MoonLake Immunotherapeutics | -12.34M |